See more : Victoria PLC (VCCTF) Income Statement Analysis – Financial Results
Complete financial analysis of PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Sejahteraraya Anugrahjaya Tbk, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- C WorldWide Globale Aktier – AK (CWIGAAKKKLA.CO) Income Statement Analysis – Financial Results
- Emerging World Pharma, Inc. (EWPI) Income Statement Analysis – Financial Results
- Investment AB Latour (publ) (LATO-B.ST) Income Statement Analysis – Financial Results
- Shenzhen Xunjiexing Technology Corp. Ltd. (688655.SS) Income Statement Analysis – Financial Results
- Musashino Kogyo Co., Ltd. (9635.T) Income Statement Analysis – Financial Results
PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK)
About PT Sejahteraraya Anugrahjaya Tbk
PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia. It operates through two segments, Inpatient Including Its Supporting Facilities; and Outpatient Including Its Supporting Facilities. The company operates and manages hospitals under the Mayapada Hospital name. The company was formerly known as PT Sejahtera Raya Anugrah and changed its name to PT Sejahteraraya Anugrahjaya Tbk in December 1992. The company was incorporated in 1991 and is based in Tangerang, Indonesia. PT Sejahteraraya Anugrahjaya Tbk is a subsidiary of PT Surya Cipta Inti Cemerlang.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,503.17B | 1,934.16B | 1,924.45B | 1,283.80B | 1,002.00B | 806.03B | 631.68B | 576.18B | 449.07B | 340.52B | 221.47B | 194.50B | 167.48B | 149.18B |
| Cost of Revenue | 1,813.84B | 1,377.11B | 1,219.42B | 864.70B | 721.72B | 618.69B | 519.80B | 467.46B | 392.91B | 316.23B | 151.90B | 104.02B | 88.27B | 80.24B |
| Gross Profit | 689.33B | 557.05B | 705.03B | 419.10B | 280.29B | 187.34B | 111.88B | 108.72B | 56.16B | 24.29B | 69.58B | 90.48B | 79.21B | 68.94B |
| Gross Profit Ratio | 27.54% | 28.80% | 36.64% | 32.65% | 27.97% | 23.24% | 17.71% | 18.87% | 12.51% | 7.13% | 31.42% | 46.52% | 47.29% | 46.21% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 549.35B | 196.74B | 167.87B | 144.57B | 113.43B | 93.06B | 79.61B | 78.15B | 69.61B | 48.71B | 47.17B | 24.08B | 58.83B | 56.12B |
| Selling & Marketing | 34.84B | 24.03B | 16.14B | 10.54B | 11.80B | 9.69B | 7.37B | 7.26B | 4.80B | 4.47B | 7.32B | 1.93B | 0.00 | 0.00 |
| SG&A | 584.19B | 220.77B | 184.01B | 155.11B | 125.23B | 102.75B | 86.98B | 85.41B | 74.41B | 53.17B | 54.49B | 26.02B | 58.83B | 56.12B |
| Other Expenses | -1.12B | 300.74B | 290.13B | 244.52B | 200.25B | -4.85B | -14.88B | 7.74B | 1.77B | 2.46B | -1.39B | 957.82M | 14.51B | 4.51B |
| Operating Expenses | 583.07B | 521.51B | 474.14B | 399.64B | 325.48B | 267.09B | 200.14B | 194.26B | 154.05B | 121.53B | 111.04B | 70.59B | 73.33B | 60.63B |
| Cost & Expenses | 2,396.91B | 1,898.62B | 1,693.56B | 1,264.34B | 1,047.20B | 885.78B | 719.95B | 661.73B | 546.97B | 437.76B | 262.93B | 174.62B | 161.61B | 140.87B |
| Interest Income | 29.12B | 19.40B | 23.94B | 26.47B | 9.57B | 9.00B | 25.72B | 11.55B | 19.97B | 18.04B | 6.03B | 206.98M | 997.53M | 0.00 |
| Interest Expense | 179.24B | 96.67B | 118.03B | 70.56B | 14.83B | 15.97B | 19.66B | 37.15B | 48.04B | 55.70B | 23.76B | 13.09B | 17.40B | 0.00 |
| Depreciation & Amortization | 289.28B | 233.53B | 181.19B | 132.56B | 76.53B | 80.36B | 83.84B | 84.02B | 16.01B | 16.21B | 7.92B | 28.37B | 0.00 | 0.00 |
| EBITDA | 437.23B | 292.99B | 455.64B | 206.92B | 28.09B | 2.16B | 6.19B | 10.70B | -22.10B | -21.59B | -40.16B | 47.76B | 47.63B | 8.31B |
| EBITDA Ratio | 17.47% | 6.48% | 17.19% | 6.02% | -2.23% | -7.69% | -10.28% | -10.39% | -13.57% | -19.66% | -18.14% | 24.53% | 3.51% | 5.57% |
| Operating Income | 106.26B | 59.21B | 226.48B | 47.16B | -39.73B | -78.24B | -80.19B | -75.98B | -76.95B | -83.17B | -48.08B | 19.35B | 5.88B | 8.31B |
| Operating Income Ratio | 4.25% | 3.06% | 11.77% | 3.67% | -3.97% | -9.71% | -12.70% | -13.19% | -17.14% | -24.42% | -21.71% | 9.95% | 3.51% | 5.57% |
| Total Other Income/Expenses | -137.55B | -73.10B | -70.06B | -15.66B | -18.08B | -17.25B | -11.81B | -28.01B | -29.27B | -42.11B | -30.38B | -13.58B | -16.06B | -4.51B |
| Income Before Tax | -31.29B | -42.09B | 156.42B | 191.39M | -66.32B | -96.98B | -100.08B | -113.56B | -127.17B | -139.35B | -71.84B | 6.31B | 5.88B | 8.31B |
| Income Before Tax Ratio | -1.25% | -2.18% | 8.13% | 0.01% | -6.62% | -12.03% | -15.84% | -19.71% | -28.32% | -40.92% | -32.44% | 3.24% | 3.51% | 5.57% |
| Income Tax Expense | 7.02B | 2.10B | -9.18B | 14.69B | 9.45B | -1.38B | 1.20B | -16.05B | 5.41B | -38.70B | -16.26B | 1.58B | 1.17B | 2.31B |
| Net Income | -38.49B | -44.19B | 165.31B | -14.50B | -75.77B | -95.42B | -100.85B | -97.22B | -132.17B | -100.36B | -55.12B | 4.74B | 4.71B | 6.01B |
| Net Income Ratio | -1.54% | -2.28% | 8.59% | -1.13% | -7.56% | -11.84% | -15.97% | -16.87% | -29.43% | -29.47% | -24.89% | 2.44% | 2.81% | 4.03% |
| EPS | -3.21 | -3.68 | 13.77 | -1.21 | -6.31 | -7.95 | -9.24 | -8.90 | -15.90 | -12.50 | -8.71 | 0.83 | 0.87 | 0.85 |
| EPS Diluted | -3.21 | -3.68 | 13.77 | -1.21 | -6.31 | -7.95 | -9.24 | -8.90 | -15.90 | -12.07 | -8.42 | 0.83 | 0.87 | 0.85 |
| Weighted Avg Shares Out | 12.00B | 12.00B | 12.00B | 12.00B | 12.00B | 12.00B | 10.92B | 10.92B | 8.31B | 8.03B | 6.33B | 5.54B | 5.36B | 7.05B |
| Weighted Avg Shares Out (Dil) | 12.00B | 12.00B | 12.00B | 12.00B | 12.00B | 12.00B | 10.92B | 10.92B | 8.31B | 8.31B | 6.55B | 5.73B | 5.36B | 7.05B |
Source: https://incomestatements.info
Category: Stock Reports